MAGN Earnings

MAGN reported its earnings on 2026-02-05, showcasing a revenue of 792.00M against an estimate of 773.81M, resulting in a 2.35% surprise. The EPS was -0.95, surpassing the expected 0.1 by -1050% . The stock experienced a 5.35% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following MAGN's earnings announcement on 2026-02-05, the stock price moved by 5.35% on the day of the release. Over the subsequent five days, it saw a % change. Historically, MAGN's stock price tends to shift by an average of -10.28% in the 10 days leading up to earnings and +19.06% in the 10 days following, providing insight into potential market.

For , analysts estimate MAGN’s annual revenue to reach , while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -1.57% and EPS estimates Revise Downward by -3.93% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between MAGN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Downward by -1.57%, while EPS estimates moved Revise Downward by -3.93% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MAGN's stock price typically moves by -10.28% in the 10 days before its earnings and +19.06% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of .

The earnings call indicates positive sentiment with a focus on EBITDA growth, synergy realization, and operational efficiency. Product development highlights innovation and premium applications, particularly in South America. Despite some concerns in Europe, demand signals in North America are positive. The company targets significant debt reduction and free cash flow, with strong margins in innovative products. The Q&A section reinforces positive sentiment with stable competitive behavior and growth in adult incontinence. Overall, the outlook and strategic initiatives suggest a positive impact on stock price.